No profile data available.
Indaptus Therapeutics, Inc. (INDP) is a healthcare company in the additional cancer treatment drugs industry, based in New York, United States, with about 5 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$20.85 million. Its market capitalization was $334.44 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products.
Indaptus Therapeutics reported $0 in revenue for fiscal year 2025.
$334.44 million as of October 9, 2026.
Listed companies of a similar size in the same industry (additional cancer treatment drugs) include Autolus Therapeutics plc (AUTL), Aura Biosciences, Inc. (AURA), Artiva Biotherapeutics, Inc. (ARTV), Allogene Therapeutics, Inc. (ALLO).